SBI Life Insurance Company Ltd
SBI Life Insurance Company Ltd is engaged in the business of life insurance and annuity. It was started as a Joint-venture between State Bank of India and BNP Paribas Cardif S.A.[1]
- Market Cap ₹ 1,71,115 Cr.
- Current Price ₹ 1,706
- High / Low ₹ 2,133 / 1,700
- Stock P/E 69.3
- Book Value ₹ 190
- Dividend Yield 0.16 %
- ROCE 15.0 %
- ROE 13.7 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company is expected to give good quarter
Cons
- Stock is trading at 8.97 times its book value
- The company has delivered a poor sales growth of 6.52% over past five years.
- Tax rate seems low
- Earnings include an other income of Rs.1,948 Cr.
- Dividend payout has been low at 12.2% of profits over last 3 years
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Financial Services Financial Services Insurance Life Insurance
Part of Nifty 50 BSE 500 BSE 100 BSE 200 BSE Dollex 200
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 23,299 | 19,324 | 30,548 | 34,068 | 44,604 | 43,798 | 81,913 | 82,983 | 80,636 | 131,988 | 116,888 | 112,315 | |
| 22,505 | 18,404 | 29,479 | 32,736 | 43,130 | 42,447 | 81,040 | 82,254 | 78,713 | 129,884 | 114,112 | 111,566 | |
| Operating Profit | 794 | 920 | 1,068 | 1,332 | 1,474 | 1,351 | 872 | 730 | 1,923 | 2,104 | 2,776 | 749 |
| OPM % | 3% | 5% | 4% | 4% | 3% | 3% | 1% | 1% | 2% | 2% | 2% | 1% |
| 183 | 129 | 139 | 156 | 266 | 529 | 867 | 1,032 | 51 | 50 | 0 | 1,948 | |
| Interest | 4 | 5 | 5 | 6 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 34 | 37 | 48 | 59 | 92 | 89 | 99 | 75 | 68 | 76 | 84 | 0 |
| Profit before tax | 939 | 1,007 | 1,154 | 1,422 | 1,642 | 1,790 | 1,640 | 1,687 | 1,906 | 2,078 | 2,693 | 2,697 |
| Tax % | 13% | 16% | 17% | 19% | 19% | 21% | 11% | 11% | 10% | 9% | 10% | 8% |
| 815 | 844 | 955 | 1,150 | 1,327 | 1,422 | 1,456 | 1,506 | 1,721 | 1,894 | 2,413 | 2,470 | |
| EPS in Rs | 8.15 | 8.44 | 9.55 | 11.50 | 13.27 | 14.22 | 14.56 | 15.05 | 17.19 | 18.91 | 24.08 | 24.63 |
| Dividend Payout % | 15% | 14% | 16% | 17% | 15% | 0% | 17% | 13% | 15% | 14% | 11% | 11% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 7% |
| 3 Years: | 12% |
| TTM: | -4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 11% |
| 3 Years: | 13% |
| TTM: | 2% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 11% |
| 3 Years: | 10% |
| 1 Year: | -3% |
| Return on Equity | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 14% |
| 3 Years: | 14% |
| Last Year: | 14% |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,001 | 1,001 | 1,002 | 1,003 |
| Reserves | 3,056 | 3,733 | 4,552 | 5,528 | 6,576 | 7,743 | 9,400 | 10,622 | 12,017 | 13,907 | 15,983 | 18,083 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 70,064 | 78,696 | 96,687 | 115,193 | 139,157 | 156,837 | 216,430 | 261,715 | 301,582 | 383,369 | 440,110 | 480,960 | |
| Total Liabilities | 74,121 | 83,429 | 102,240 | 121,720 | 146,734 | 165,580 | 226,830 | 273,337 | 314,599 | 398,277 | 457,095 | 500,046 |
| 292 | 301 | 507 | 511 | 563 | 568 | 564 | 919 | 520 | 551 | 580 | 688 | |
| CWIP | 7 | 146 | 31 | 70 | 32 | 13 | 1 | 3 | 1 | 6 | 10 | 0 |
| Investments | 69,385 | 77,843 | 95,830 | 114,436 | 139,325 | 158,813 | 218,756 | 264,437 | 304,334 | 385,590 | 447,467 | 486,367 |
| 4,437 | 5,139 | 5,871 | 6,703 | 6,814 | 6,186 | 7,509 | 7,978 | 9,743 | 12,130 | 9,038 | 12,991 | |
| Total Assets | 74,121 | 83,429 | 102,240 | 121,720 | 146,734 | 165,580 | 226,830 | 273,337 | 314,599 | 398,277 | 457,095 | 500,046 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2,711 | 5,778 | 8,525 | 10,395 | 13,473 | 19,299 | 23,878 | 21,852 | 28,656 | 29,122 | 25,547 | 34,523 | |
| -178 | -7,204 | -9,032 | -8,910 | -13,552 | -16,986 | -19,203 | -21,611 | -30,203 | -31,221 | -21,789 | -35,318 | |
| -117 | -144 | -144 | -221 | -241 | -198 | 3 | -231 | -415 | -227 | -215 | -179 | |
| Net Cash Flow | 2,416 | -1,570 | -651 | 1,264 | -321 | 2,114 | 4,677 | 10 | -1,962 | -2,327 | 3,543 | -974 |
| Free Cash Flow | 2,687 | 5,600 | 8,377 | 10,288 | 13,325 | 19,210 | 23,763 | 21,785 | 28,581 | 29,008 | 25,441 | 34,338 |
| CFO/OP | 341% | 628% | 798% | 780% | 955% | 1,473% | 2,802% | 3,094% | 1,532% | 1,426% | 956% | 4,745% |
Ratios
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Working Capital Days | 0 | -6 | 3 | 3 | 4 | 11 | 1 | -3 | 1 | 4 | 2 | 4 |
| ROCE % | 25% | 23% | 23% | 24% | 22% | 22% | 17% | 15% | 15% | 15% | 17% | 15% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets Under Management (AUM) ₹ Billion |
|
|||||||||
| New Business Premium (NBP) ₹ Billion |
||||||||||
| Number of Individual Agents Absolute |
||||||||||
| Private Market Share (Individual Rated Premium) % |
||||||||||
| Solvency Ratio x |
||||||||||
| Value of New Business (VoNB) Margin % |
||||||||||
| 13th Month Persistency (Premium Basis) % |
||||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
8 Jun - Please find attached Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015
-
Cancellation Of Investor/ Analyst Meet
4 Jun - SBI Life cancels Citi India Conference 2026 and ICICI Securities India Investor Conference participation.
-
Announcement under Regulation 30 (LODR)-Change in Management
30 May - President–Operations & IT Durgadas G superannuates on May 31, 2026.
-
Announcement under Regulation 30 (LODR)-Change in Management
29 May - SBI Life appoints Mr. Ramesh Venkateshamurthy as Deputy CEO from May 29, 2026.
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 29 May
Annual reports
Concalls
-
Apr 2026Transcript PPT REC
-
Apr 2026TranscriptAI SummaryPPT
-
Feb 2026Transcript PPT
-
Oct 2025Transcript PPT REC
-
Jul 2025Transcript PPT
-
May 2025Transcript PPT REC
-
Jan 2025Transcript PPT
-
Oct 2024Transcript PPT
-
Jul 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Oct 2023Transcript PPT
-
Jul 2023Transcript PPT
-
Jun 2023TranscriptAI SummaryPPT
-
May 2023TranscriptPPT
-
Jan 2023TranscriptPPT
-
Nov 2022TranscriptPPT
-
Aug 2022TranscriptPPT
-
May 2022TranscriptPPT
-
May 2020TranscriptAI SummaryPPT
-
Jan 2018TranscriptAI SummaryPPT
Product Portfolio
The company offers a range of life insurance products, including 25 individual and 8 group plans across protection, pension, savings, and health solutions. Its portfolio includes participating, non-participating, pension, gratuity, leave encashment, superannuation, annuity, unit-linked, variable, health, and micro-insurance products. [1][2]